https://scholars.lib.ntu.edu.tw/handle/123456789/492453
標題: | Nonmedical prescription drug use of analgesics and sedatives/hypnotics in Taiwan: Results from the 2014 National Survey of Substance Use | 作者: | LIAN-YU CHEN Chen Y.-L. Tsay W.-I. Wu S.-C. Chen Y.-T. Hsiao P.-C. Yu Y.-H. Ting T.-T. Chen C.-Y. YU-KANG TU JIUN-HAU HUANG Yang H.-J. Li C.-Y. Strong C. Yen C.-F. Yen C.-F. Hsu J. WEI J. CHEN |
公開日期: | 1-九月-2019 | 出版社: | Elsevier Inc. | 卷: | 15 | 起(迄)頁: | Artical Number 100900 | 來源出版物: | Preventive Medicine Reports | 摘要: | Nonmedical prescription drug use (NMPDU)has become a major public health issue but little is known in Asian populations. This study aimed to investigate the prevalence and correlates of NMPDU in Taiwan. Participants from the 2014 national survey of 17,837 individuals, aged 12 to 64 year, completed anonymously a computer-assisted self-interview. Past-year prescription drug use was divided into medical use only (MUO)and nonmedical use (NMU), defined as using the drug without a prescription, or more frequently, or in larger doses than prescribed. Problematic alcohol use was measured using the Alcohol Use Disorders Identification Test (AUDIT), problematic drug use using the 20-item Drug Abuse Screening Test (DAST), and depressive symptoms using the Center for Epidemiological Study-Depression (CES-D). The prevalence of past-year NMU was 3.02% for analgesics, 0.71% for sedatives/hypnotics, and 3.66% for either drug, with a very small overlap of NMU between analgesics and sedatives/hypnotics (0.07%). When individuals with NMU were compared to those without NMU (Non-NMU)and those with MUO, respectively, some correlates consistently identified, including young adulthood, tobacco smoking, alcohol drinking, and greater AUDIT's scores for analgesics, as well as hard drug use and greater DAST's scores for sedatives/hypnotics. NMU was associated with greater CES-D's scores for both analgesics and sedatives/hypnotics when compared to Non-NMU but not to MUO. Robust correlates of NMPDU could offer implications for development of prevention strategies of NMPDU. ? 2019 |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85065867611&doi=10.1016%2fj.pmedr.2019.100900&partnerID=40&md5=9d554559ea5274652c042f2a9f24bbe3 https://scholars.lib.ntu.edu.tw/handle/123456789/492453 |
ISSN: | 2211-3355 | DOI: | 10.1016/j.pmedr.2019.100900 | SDG/關鍵字: | alprazolam; analgesic agent; brotizolam; clonazepam; codeine phosphate; estazolam; fludiazepam; guaifenesin; hypnotic sedative agent; ipratropium bromide; lorazepam; midazolam maleate; morphine; paracetamol plus tramadol; tiotropium bromide; tramadol; triazolam; zaleplon; zolpidem tartrate; adolescent; adult; alcohol consumption; Article; Center for Epidemiological Studies Depression Scale; child; controlled study; depression; drinking behavior; drug use; Fagerstrom Test for Nicotine Dependence; female; human; major clinical study; male; prescription drug misuse; prevalence; priority journal; screening test; smoking; substance use; Taiwan |
顯示於: | 健康行為與社區科學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。